Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net Sales	$ 10,654,483	$ 3,356,090
Cost of Goods Sold	8,732,097	2,206,991
Gross Profit	1,922,386	1,149,099
Operating Expenses
Research and development	189,210	59,314
Selling General and Administrative Expenses	5,264,379	3,101,226
Loss on impairment of goodwill and intangibles	0	1,138,203
Total Operating Expenses	5,453,589	4,298,743
Operating Loss	(3,531,203)	(3,149,644)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	2,302	43,828
Interest expense	(392,939)	(4,056)
Loss on change in Fair Market Value of Contingent Consideration	(619,999)	(240,000)
Gain on Settlement of Contingent Consideration (Note 2)	0	1,700,000
Total Other Income (Expense)	(1,010,636)	1,499,772
Loss Before Provision for Income Taxes	(4,541,839)	(1,649,872)
Benefit from Income Taxes	0	0
Net Loss	(4,541,839)	(1,649,872)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(362,250)	(362,250)
Net Loss attributable to common stockholders	$ (4,904,089)	$ (2,012,122)
Basic and Diluted Loss Per Common Share	$ (0.28)	$ (0.16)
Weighted Average Shares Outstanding - basic and diluted	17,328,564	12,928,174